Notify me when Patrick J. Heron files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MBX | MBX BIOSCIENCES, INC. | Common Stock, $0.0001 par value per share | 12% | $72,562,680 | +$9,264,602 | 5,224,095 | +15% | Patrick J. Heron | 26 Sep 2025 |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | Common Stock, par value $0.0001 per share | 7.5% | $130,399,321 | 8,943,712 | Patrick J. Heron | 18 Aug 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|